12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Nexavar sorafenib regulatory update

Bayer submitted an sNDA to FDA and a regulatory application to EMA for Nexavar sorafenib to treat locally advanced or metastatic, radioactive...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >